The high NPV [97.3% (95% CI, 93.8–99.1)] of the sFlt-1/PlGF ratio (cutoff ≤38) observed in this sub-analysis allows clinicians to rule out preeclampsia within 1 week in Chinese women with a high degree of confidence, thus supporting clinical decision making on whether to hospitalize patients or not. The gene discussed is PGF; the disease is preeclampsia.